Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Albert

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Hematology/Oncology|April 7, 2023
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic LeukemiaTimothy J D Ohlsen, Erin R Rudzinski, Sandra D Bohling, et al.
Oncotarget|November 8, 2017
Size-based detection of sarcoma circulating tumor cells and cell clustersMasanori Hayashi, Peixuan Zhu, Gregory McCarty, et al.
Cancer|June 29, 2016
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNAMasanori Hayashi, David Chu, Christian F Meyer, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Cancer|September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomasSteven G DuBois, Theodore W Laetsch, Noah Federman, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
The American Journal of Surgical Pathology|December 27, 2018
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal TumorsJessica L Davis, Christina M Lockwood, Bradley Stohr, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Hematology/Oncology|April 7, 2023
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic LeukemiaTimothy J D Ohlsen, Erin R Rudzinski, Sandra D Bohling, et al.
Oncotarget|November 8, 2017
Size-based detection of sarcoma circulating tumor cells and cell clustersMasanori Hayashi, Peixuan Zhu, Gregory McCarty, et al.
Cancer|June 29, 2016
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNAMasanori Hayashi, David Chu, Christian F Meyer, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Cancer|September 12, 2018
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomasSteven G DuBois, Theodore W Laetsch, Noah Federman, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
The American Journal of Surgical Pathology|December 27, 2018
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal TumorsJessica L Davis, Christina M Lockwood, Bradley Stohr, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.
Pageof 4